Quantitative phosphoproteomic analysis of RIP3-dependent protein phosphorylation in the course of TNF-induced

Chuan-Qi Zhong1, Yuanyue Li, Daowei Yang

  • 1State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Biology, School of Life Sciences, Xiamen University, Xiamen, Fujian, P. R. China.

Proteomics
|January 24, 2014
PubMed

Insights

This study identifies novel RIP3-dependent phosphorylation sites crucial for tumor necrosis factor (TNF)-induced necroptosis in L929 cells. These findings advance our understanding of programmed cell death mechanisms.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumor necrosis factor (TNF) induces programmed cell death, known as necroptosis.
  • Receptor interacting protein 3 (RIP3) is essential for TNF-induced necroptosis, but its downstream phosphorylation events remain largely uncharacterized.

Purpose of the Study:

  • To investigate the global phosphoproteome changes induced by TNF in L929 cells with and without RIP3.
  • To identify RIP3-dependent phosphorylation sites involved in TNF-induced necroptosis.

Main Methods:

  • Quantitative mass spectrometry (MS)-based phosphoproteomic analysis.
  • Comparison of wild-type (RIP3(+/+)) and RIP3-knockdown L929 cells treated with TNF over time (0.5, 2, and 4 hours).

Main Results:

  • Identification of 8058 phosphopeptides, 6892 phosphorylation sites, and 2762 proteins.
  • Discovery of 174, 167, and 177 distinct RIP3-dependent phosphorylation sites at 0.5, 2, and 4 hours post-TNF treatment, respectively.
  • Most identified sites were novel compared to previous studies in macrophages and fibroblasts.

Conclusions:

  • This study provides a comprehensive map of RIP3-dependent phosphorylation in TNF-induced necroptosis in L929 cells.
  • The identified phosphorylation sites offer new targets for understanding necroptosis regulation and potential therapeutic interventions.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.6K